Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).

  title={Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019).},
  author={Harsharnjit Singh Gill and Kay J. Rutherfurd and Jaya Prasad and Pramod K. Gopal},
  journal={The British journal of nutrition},
  volume={83 2},
Consumption of lactic acid bacteria (LAB) has been suggested to confer a range of health benefits including stimulation of the immune system and increased resistance to malignancy and infectious illness. In the present study, the effects of feeding Lactobacillus rhamnosus (HN001, DR20), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019, DR10) on in vivo and in vitro indices of natural and acquired immunity in healthy mice were examined. Mice were fed daily with L. rhamnosus, L… 

Figures and Tables from this paper

Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice.

  • Q. ShuH. Gill
  • Biology
    FEMS immunology and medical microbiology
  • 2002
Results demonstrate that feeding the probiotic L. rhamnosus HN001 to mice can reduce the severity of E. coli O157:H7 infection, and suggest that this reduction may be associated with enhanced humoral and cellular immune responses.

Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis.

Overall, SYN supplementation in carcinogen-treated rats primarily modulated immune functions in the PP, coinciding with a reduced number of colon tumours.

Viability and dose–response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice

It is demonstrated that L. rhamnosus HN001 exhibits dose-dependent effects on the phagocytic defence system of mice, and suggests that while the innate cellular immune system is responsive to killed forms of food-borne bacteria, specific gut mucosal immunity may only be stimulated by live forms.

Inability of probiotic bacterial strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 to induce human platelet aggregation in vitro.

These test probiotic strains HN001 and HN019 are less likely to participate in the pathogenesis of infective endocarditis or other thrombotic disorders with regard to platelet aggregation factors.



Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection.

Bacterial adhesion to enterocytes, fecal colonization, or both seem to be valuable selection criteria for immunomodulation, and antiinfective mechanisms of defense can be enhanced after ingestion of specific lactic acid bacteria strains.

Probiotics and the immune state

The role played by lactic acid bacteria in various biological functions of the host has been extensively reported and great emphasis has been laid on the antitumour activity exerted by yoghurt and by milks fermented with Lactobacillus acidophilus.

Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus.

Higher levels of anti-shigella antibodies were found both in sera and in small intestinal fluid of mice treated with fermented milk, suggesting that the protective immunity could be mediated by the mucosal tissue.

Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019)

The results demonstrate that dietary consumption of B. lactis HN019 can enhance natural immunity in healthy elderly subjects, and that a relatively short-term dietary regime is sufficient to impart measurable improvements in immunity that may offer significant health benefits to consumers.

Stimulation of the Immune System by Lactic Cultures

Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk intake.

Results indicate that lactic acid bacteria which can persist in the gastrointestinal tract can act as adjuvants to the humoral immune response.

Lactic Acid Bacteria in the Treatment of Acute Rotavirus Gastroenteritis

It is concluded that certain strains of lactic acid bacteria, particularly LGG, promote serum and intestinal immune responses to rotavirus, and thus may be important in establishing immunity against rotav virus reinfections.

Immunogenicity of Bifidobacterium breve and change in antibody production in Peyer's patches after oral administration.

Results suggest that when serum antibody to B. breve increases significantly, anti-B.

Lactobacillus casei Inhibits Antigen-Induced IgE Secretion through Regulation of Cytokine Production in Murine Splenocyte Cultures

This is the first demonstration that a nonpathogenic microorganism, L. casei, can inhibit antigen-induced IgE production through induction of IL-12 secretion by macrophages, suggesting a potential use of this organism in preventing IgE-mediated allergy.

Effect of perorally administered lactobacilli on macrophage activation in mice

Observations show that L. casei and L. bulgaricus given by p.o. administration are able to activate macrophages in mice and suggest that these bacteria, when passing through the intestinal tract, may be responsible for the enhanced host immune response.